News

Empassion Health Promises Substantial Cost Savings for Serious Illness Care

Empassion Health Promises Substantial Cost Savings for Serious Illness Care

Empassion Health Announces Significant Cost Savings for Medicare Plans

Empassion Health, Inc., a leading managed care provider focused on delivering quality care for adults facing serious illnesses, recently unveiled recent findings highlighting a remarkable 35% reduction in total care costs per patient in their final year of life. This groundbreaking study encompasses data from thousands of patients and reinforces Empassion’s commitment to providing exceptional care while ensuring substantial cost efficiencies.

The Challenge in High-Cost Care

Patients enduring serious health conditions often find themselves not only overwhelmed but also under-supported within the current healthcare system. Astoundingly, a mere 5% of patients eligible for palliative care access the benefits of home-based services, which leaves the majority vulnerable to unnecessary hospital visits and fragmented treatment. These patients represent a small but significant segment of the Medicare population, accounting for a staggering 25% of total Medicare expenditures. Consequently, families grapple with a lack of education and support during crucial times when they need it most.

Understanding the Burden

This vulnerability highlights a pressing issue in healthcare today: the need for compassionate support tailored to those navigating serious illnesses. Families often feel isolated and uninformed, struggling under the weight of a system that prioritizes institutional care over personalized support.

A Fresh Approach with the Empassion Model

Empassion Health introduces a transformative model that centers on providing palliative care directly within patients’ homes, coordinating comprehensive care that addresses medical, emotional, and social needs. The goal is simple yet profound: to enhance the quality of life for patients and their families. The recent Savings Study included extensive analysis from over 45,000 adults across various Medicare programs, ensuring a detailed and diverse understanding of Empassion's impact.

Study Results: Evidence of Effectiveness

The findings of this important study are nothing short of impressive:

  • Patients experienced an overall savings of 35% during their last year, demonstrating the financial benefits of in-home palliative care.
  • Those receiving both palliative care and hospice services averaged savings of $33,000, equivalent to a remarkable 41% reduction in costs.
  • Patients solely utilizing in-home palliative care experienced an average savings of $7,000.
  • The study revealed a 35% decrease in hospital expenditures due in large part to improved in-home support and care coordination.
  • Empassion showcased a notable 70% utilization rate of hospice services, significantly higher than the national average of 50%, with patients experiencing median lengths of stay in hospice and palliative care that far exceeded national norms.
  • A staggering 90% patient satisfaction rate was recorded, with many patients rating their experience at the highest level.

Robin Heffernan, Co-Founder and CEO of Empassion, emphasized the study's findings, stating, "The bottom-line results of this Empassion study prove that care, compassion, and cost savings do not have to be mutually exclusive. By maintaining a focus on the patient experience, we can help health plans address complex care challenges sustainably."

Empassion's Vision for the Future

Empassion is dedicated to revolutionizing care for adults living with serious illnesses, striving to ensure they can experience more good days. Operating in 45 states, Empassion collaborates with a vast network of community-based supportive care providers, ensuring the utmost quality in their services. Their comprehensive programs cater to a wide array of populations, including those under Original Medicare, Medicare Advantage, and Dual health plans.

Frequently Asked Questions

What is the main finding of the Empassion study?

The Empassion study revealed a 35% reduction in costs for patients in their final year of life while maintaining high-quality care outcomes.

How does Empassion Health deliver its services?

Empassion Health provides in-home palliative care and ensures comprehensive care coordination through local community providers.

Why is there a low rate of palliative care utilization?

Only 5% of eligible patients receive home-based palliative care, primarily due to a fragmented healthcare system that does not prioritize such services.

How does Empassion address patient needs?

Empassion’s approach includes catering to medical, emotional, and social needs, ensuring patients and families receive well-rounded support.

What is Empassion's mission?

Empassion aims to provide high-quality care for adults living with serious illnesses, allowing them to enjoy more good days with the support they need.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 5

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 4

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 4

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 3

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 6

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 3

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading

Top 5 Most Recently Viewed Articles

Auburn National Bancorporation's Earnings Surge in Q3

Updated Category News Views 32

Auburn National Bancorporation's Q3 Earnings Overview Auburn National Bancorporation, Inc. recently announced its financial results for the third quarter of 2024. The report highlighted significant improvements in key financial metrics compared to the same quarter last year. Financial Performance Highlights For the third quarter of 2024, Auburn National Bancorporation...

Continue Reading
NEO Battery Innovations: Stock Options for Future Growth

Updated Category News Views 211

NEO Battery Materials Grants Incentive Stock Options TORONTO — NEO Battery Materials Ltd. (“NEO” or the “Company”) (TSX-V: NBM) (OTC: NBMFF), known for pioneering low-cost silicon anode materials, has recently announced the granting of incentive stock options to several of its directors and officers. This move allows them to acquire a total of 510,000 common...

Continue Reading
Zventus Partners with TecNM to Enhance Software Development Skills

Updated Category News Views 224

Introduction to a New Era in Software Development In a significant collaboration aimed at enhancing software development capabilities, Zventus, a prominent global consulting firm, has joined forces with the Ensenada Institute of Technology. This partnership marks an important milestone in connecting academic learning with crucial industry needs. The Purpose Behind the...

Continue Reading
Robert Reich Critiques Trump's Tax Plans and Corporate Gains

Updated Category News Views 575

Robert Reich's Perspective on Proposed Tax Cuts Renowned economist and former U.S. Secretary of Labor Robert Reich has voiced strong concerns regarding the tax reduction proposals from the administration led by Donald Trump. In a recent statement, Reich described the intended cuts as "an absolutely shameless giveaway" that could potentially escalate the federal deficit by...

Continue Reading
Eli Lilly Boosts Infectious Disease Strategy in 2026

Updated Category News Views 11

What's Eli Lilly Cooking Up? So, Eli Lilly is throwing some serious chips on the table with these new acquisitions. The pharma giant is snapping up not one, not two, but three companies—all to bolster its infectious disease game. Now, if you've been around the market block as long as I have, you know they aren't just doing this for fun. It's about strategic positioning,...

Continue Reading